CELEX: 62015TB0713
Language: en
Date: 2016-03-16 00:00:00
Title: Case T-713/15: Order of the General Court of 16 March 2016 — Pharm-a-care Laboratories v OHIM — Pharmavite (VITAMELTS) (Community trade mark — Invalidity proceedings — Withdrawal of the application for a declaration of invalidity — No need to adjudicate)

17.5.2016   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 175/16
            
         Order of the General Court of 16 March 2016 — Pharm-a-care Laboratories v OHIM — Pharmavite (VITAMELTS)
   (Case T-713/15) (1)
   
   ((Community trade mark - Invalidity proceedings - Withdrawal of the application for a declaration of invalidity - No need to adjudicate))
   (2016/C 175/18)
   Language of the case: English
   
      Parties
   
   
      Applicant: Pharm-a-care Laboratories Pty. Ltd (Sydney, Australia) (represented by: I.A. De Freitas, lawyer)
   
      Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: E. Zaera Cuadrado, acting as Agent)
   
      Other party to the proceedings before the Board of Appeal of OHIM: Pharmavite LLC (California, United States)
   
      Re:
   
   Action brought against the decision of the First Board of Appeal of OHIM of 10 September 2015 (Cases R 2649/2014-1) concerning invalidity proceedings between Pharmvite LLC and Pharm-a-care Laboratories Pty. Ltd.
   
      Operative part of the order
   
   
               1.
            
            
               There is no longer any need to adjudicate in the action.
            
         
               2.
            
            
               Pharm-a-care Laboratories Pty. Ltd shall bear its own costs and shall pay the costs incurred by the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM).
            
         
      (1)  OJ C 38, 1.2.2016.